The HHS appoints these leadership positions as it looks to “reform” the FDA, which has recently faced a high turnover in leadership.

The FDA's latest efforts to curb the illicit US medicines trade are primarily centred around weight loss and fat-reducing peptides.

Though yet to be finalised, the initial recommendation would mean the injectable PrEP would not be covered on the NHS.

ABEC is to open a new manufacturing facility in Wilson, North Carolina, US, expanding its network for biopharmaceutical process equipment.

Encoded Therapeutics has raised $275m in a Series F financing round to advance development of its disease-modifying therapy (DMT) for Dravet syndrome, with an eye also on initiati ...

A survey of 175 pharma executives highlights an increasing reluctance to launch in lower-value markets, alongside a heightened focus on RWE.

Biotechs and investors are increasingly altering their strategies amid changes in the development and commercial landscape.

As regulatory enforcement surges, life science manufacturers must shift away from paper-based systems to ensure compliance.

The FDA has granted RMAT designation to RiboX Therapeutics’ investigational treatment RXRG001 for RIX and hyposalivation.

Thoracic oncologists previously touted the potential of Bayer's Hyrnuo in HER2-mutant NSCLC in both the first- and second-line settings.

Novartis has signed an agreement with Alteogen that could be worth up to $3.22bn for the development and commercialisation of subcutaneous drug formulations using Alteogen’s ALT-B4 technology.

The LSTM in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases.